Pentacel® Vaccine Delay
The Texas Vaccines for Children (TVFC) Program was notified on November 30, 2015, by the Centers for Disease Control and Prevention regarding a temporary manufacturing delay of Sanofi Pastuer's Pentacel® vaccine (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate Vaccine). The vaccine delay will result in immediate vaccine allocation of this project to all VFC programs nationwide. The vaccine delay is anticipated to last through the summer of 2016.
In order to ensure that all TVFC providers have access to this vaccine over the next few months, TVFC provider Maximum Stock Levels (MSLs) for Pentacel® will be reduced immediately. However, further vaccine allocation reductions could be implemented based on manufacture and CDC guidance.
Options to reduce the use of Pentacel® include the use of single vaccines for some populations and the use of alternative combination vaccines. Providers should continue to follow the recommended immunization schedule and ensure that patients receive all recommended doses of DTaP, Hib, and polio vaccines.
For additional information, please see the following documents:
Measles Vaccine Frequently Asked Questions
Measles Overview for School Nurses
To learn more about how you can protect babies with vaccinations, visit one of our infant immunizations pages:
Proteja a sus bebés. Cada vacuna cuenta. –
Información en Español
Adolescent Immunization Information
CollegeVaccineRequirements.com - Your source for information on MCV4 vaccine requirements